Featured Archives - Life Sciences Times

PureTech Launches Celea Therapeutics to Advance Treatment of Serious Respiratory Diseases

August 12, 2025

First Patient Dosed in Phase 3 Trial of Potential Dravet Syndrome Treatment

August 11, 2025

Boston IVF Adds Dr. Mary Morris to Massachusetts Fertility Team, Expanding Expertise in Oncofertility and Family Building

August 7, 2025

THIS WEEK'S STORIES

Cardiosense Names Dr. John Martin as EVP and Chief Medical Officer Following FDA Clearance of CardioTag Device

August 12, 2025

Trinity Life Sciences Unveils Digital Affinity Platform to Enhance HCP Engagement

August 12, 2025

2Life Communities Names Denise McQuaide Chief of Middle Market Innovation to Lead New Senior Living Model

August 7, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Featured

PureTech Launches Celea Therapeutics to Advance Treatment of Serious Respiratory Diseases

First Patient Dosed in Phase 3 Trial of Potential Dravet Syndrome Treatment

Boston IVF Adds Dr. Mary Morris to Massachusetts Fertility Team, Expanding Expertise in Oncofertility and Family Building

Silversmith Capital Partners Closes $1.7 Billion Fund V, Names Sri Rao Managing Partner

P&G Names Shailesh Jejurikar as Next CEO; Jon Moeller to Become Executive Chairman

Most Read

KnoWEwell Names Functional Medicine Leader Dr. Patrick Hanaway as Chief Medical Officer

Survey Finds Pediatricians Prefer Genexa’s Ingredient Profiles Over Children’s Tylenol® Products

FDA Grants De Novo Authorization to ArteraAI Prostate, First AI-Powered Digital Pathology Tool for Prostate Cancer Prognosis

Alto Neuroscience Appoints Raymond Sanchez, M.D., to Board of Directors

EDITOR PICKS

PureTech Launches Celea Therapeutics to Advance Treatment of Serious Respiratory Diseases

First Patient Dosed in Phase 3 Trial of Potential Dravet Syndrome Treatment

Boston IVF Adds Dr. Mary Morris to Massachusetts Fertility Team, Expanding Expertise in Oncofertility and Family Building

THIS WEEK'S STORIES

Cardiosense Names Dr. John Martin as EVP and Chief Medical Officer Following FDA Clearance of CardioTag Device

Trinity Life Sciences Unveils Digital Affinity Platform to Enhance HCP Engagement

2Life Communities Names Denise McQuaide Chief of Middle Market Innovation to Lead New Senior Living Model

POPULAR CATEGORY

ABOUT US

FOLLOW US